Find Norgestimate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Dexnorgestrel acetime, 35189-28-7, Anti-norgestimate, Norgestimate, e-, Norgestimato, Norgestimatum
Molecular Formula
C23H31NO3
Molecular Weight
369.5  g/mol
InChI Key
KIQQMECNKUGGKA-NMYWJIRASA-N
FDA UNII
NKX8DN6TY9

Norgestimate
Norgestimate was first described in the literature in 1977. It was developed by Ortho Pharmaceutical Corporation as part of an effort to develop new hormonal contraceptives with reduced adverse effects. It is commonly formulated with [ethinylestradiol] as a combined oral contraceptive that can also be used to treat moderate acne vulgaris. Norgestimate was granted FDA approval on 29 December 1989.
1 2D Structure

Norgestimate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate
2.1.2 InChI
InChI=1S/C23H31NO3/c1-4-22-12-10-19-18-9-7-17(24-26)14-16(18)6-8-20(19)21(22)11-13-23(22,5-2)27-15(3)25/h2,14,18-21,26H,4,6-13H2,1,3H3/b24-17+/t18-,19+,20+,21-,22-,23-/m0/s1
2.1.3 InChI Key
KIQQMECNKUGGKA-NMYWJIRASA-N
2.1.4 Canonical SMILES
CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34
2.1.5 Isomeric SMILES
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)OC(=O)C)CCC4=C/C(=N/O)/CC[C@H]34
2.2 Other Identifiers
2.2.1 UNII
NKX8DN6TY9
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Norgestrel Oxime Acetate

2.3.2 Depositor-Supplied Synonyms

1. Dexnorgestrel Acetime

2. 35189-28-7

3. Anti-norgestimate

4. Norgestimate, E-

5. Norgestimato

6. Norgestimatum

7. Norgestimatum [inn-latin]

8. Norgestimato [inn-spanish]

9. Orf-10131

10. Nkx8dn6ty9

11. [(3e,8r,9s,10r,13s,14s,17r)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] Acetate

12. (+)-13-ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one Oxime Acetate (ester)

13. 20799-27-3

14. Chebi:50815

15. Orf 10131

16. Rwj 10131

17. Ncgc00181353-01

18. (17alpha)-17-(acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime

19. Dsstox_cid_26922

20. Dsstox_rid_82018

21. Dsstox_gsid_46922

22. 107382-52-5

23. D-13beta-ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one Oxime

24. Rwj-10131

25. Cas-35189-28-7

26. Norgestimate (usp/inn)

27. Nsc-759159

28. Unii-nkx8dn6ty9

29. Schembl38317

30. Schembl38318

31. Chembl1200934

32. Dtxsid1046922

33. Norgestimate, >=97% (hplc)

34. Norgestimate For System Suitability

35. Tox21_112811

36. Ac-655

37. (3e)-17alpha-ethynyl-3-(hydroxyimino)-18a-homoestr-4-en-17beta-yl Acetate

38. Akos015917555

39. Tox21_112811_1

40. Db00957

41. Ncgc00344561-01

42. As-12305

43. D05209

44. 351n287

45. A822635

46. J-019983

47. 18,19-dinorpregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, 3-oxime, (3e,17alpha)-

48. (1s,2r,5e,10r,11s,14r,15s)-15-ethyl-14-ethynyl-5-(hydroxyimino)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl Acetate

49. [(3e,8r,9s,10r,13s,14s,17r)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] Acetate;norgestimate

50. 18,19-dinorpregn-4-en-20-yn-3-one, 17-(acetyloxy)-13-ethyl-, 3-oxime, (3e,17.alpha.)-

2.4 Create Date
2006-05-23
3 Chemical and Physical Properties
Molecular Weight 369.5 g/mol
Molecular Formula C23H31NO3
XLogP34.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass369.23039385 g/mol
Monoisotopic Mass369.23039385 g/mol
Topological Polar Surface Area58.9 Ų
Heavy Atom Count27
Formal Charge0
Complexity744
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

Contraceptives, Oral, Synthetic; Norgestrel/analogs & derivatives

National Library of Medicine's Medical Subject Headings online file (MeSH, 2009)


Norgestimate/ethinyl estradiol is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. /Included in US product label/

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (December 2010). Available from, as of March 30, 2011: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=33976


4.2 Drug Warning

/BOXED WARNING/ WARNINGS: CARDIOVASCULAR RISK ASSOCIATED WITH SMOKING. Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, combination oral contraceptives, including MonoNessa, should not be used by women who are over 35 years of age and smoke.

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (Updated: February 2015). Available from, as of April 23, 2015: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=704ba4ae-edd0-4298-a399-03a49f8411c7


Oral contraceptives should not be used in women who currently have the following conditions: thrombophlebitis or thromboembolic disorders; a past history of deep vein thrombophlebitis or thromboembolic disorders; cerebral vascular or coronary artery disease (current or past history); valvular heart disease with complications; severe hypertension; diabetes with vascular involvement; headaches with focal neurological symptoms; major surgery with prolonged immobilization; known or suspected carcinoma of the breast or personal history of breast cancer; carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia; undiagnosed abnormal genital bleeding; cholestatic jaundice of pregnancy or jaundice with prior pill use; acute or chronic hepatocellular disease with abnormal liver function; hepatic adenomas or carcinomas; known or suspected pregnancy; hypersensitivity to any component of this product.

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (December 2010). Available from, as of March 30, 2011: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=33976


The use of oral contraceptives is associated with increased risks of several serious conditions including myocardial infarction, thromboembolism, stroke, hepatic neoplasia, and gallbladder disease, although the risk of serious morbidity or mortality is very small in healthy women without underlying risk factors. The risk of morbidity and mortality increases significantly in the presence of other underlying risk factors such as hypertension, hyperlipidemias, obesity and diabetes.

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (December 2010). Available from, as of March 30, 2011: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=33976


Oral contraceptives have been shown to increase both the relative and attributable risks of cerebrovascular events (thrombotic and hemorrhagic strokes), although, in general, the risk is greatest among older (>35 years), hypertensive women who also smoke. Hypertension was found to be a risk factor for both users and nonusers, for both types of strokes, and smoking interacted to increase the risk of stroke. In a large study, the relative risk of thrombotic strokes has been shown to range from 3 for normotensive users to 14 for users with severe hypertension. The relative risk of hemorrhagic stroke is reported to be 1.2 for non-smokers who used oral contraceptives, 2.6 for smokers who did not use oral contraceptives, 7.6 for smokers who used oral contraceptives, 1.8 for normotensive users and 25.7 for users with severe hypertension. The attributable risk is also greater in older women.

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (December 2010). Available from, as of March 30, 2011: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=33976


For more Drug Warnings (Complete) data for Norgestimate (44 total), please visit the HSDB record page.


4.3 Drug Indication

Norgestimate is formulated with [ethinylestradiol] as a combined oral contraceptive. It can also be given with low dose ethinylestradiol for contraception as well as the treatment of moderate acne vulgaris in women 15 years old.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Norgestimate is a progestin that suppresses ovulation for contraception and reduces free testosterone to treat moderate acne vulgaris. The therapeutic index is wide as overdoses are rare. Patients should be counselled regarding the risk of vascular problems, liver disease, hypertension, metabolic effects, headaches, and bleeding irregularities.


5.2 MeSH Pharmacological Classification

Contraceptives, Oral, Synthetic

Oral contraceptives which owe their effectiveness to synthetic preparations. (See all compounds classified as Contraceptives, Oral, Synthetic.)


Contraceptive Agents, Hormonal

Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)


5.3 Absorption, Distribution and Excretion

Absorption

Oral norgestimate has a Tmax of 0.5-2h. On day 21 of cycle 3, 17-desacetylnorgestimate reaches a Cmax of 1.82ng/mL, with a Tmax of 1.5h, and an AUC of 16.1h\*ng/mL. At the same time, norgestrel reaches a Cmax of 2.79ng/mL, with a Tmax of 1.7h, and an AUC of 49.9h\*ng/mL.


Route of Elimination

Norgestimate is 45-49% eliminated in urine and 16-49% eliminated in feces. Unchanged norgestimate is not detected in urine.


Volume of Distribution

Data regarding the volume of distribution of norgestimate are not readily available.


Clearance

Data regarding the clearance of norgestimate is not readily available.


Norgestimate (NGM) and ethinyl estradiol (EE) are rapidly absorbed following oral administration.

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (December 2010). Available from, as of March 30, 2011: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=33976


Peak serum concentrations of norelgestromin (NGMN) and ethinyl estradiol (EE) are generally reached by 2 hours after administration of MonoNessa. Accumulation following multiple dosing of the 250 ug Norgestimate (NGM)/ 35 ug dose is approximately 2-fold for NGMN and EE compared with single dose administration. The pharmacokinetics of NGMN is dose proportional following NGM doses of 180 ug to 250 ug. ... Steady-state concentrations of NGMN and NG are achieved by Day 21. Non-linear accumulation (approximately 8 fold) of norgestrel is observed as a result of high affinity binding to SHBG (sex hormone-binding globulin), which limits its biological activity.

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (December 2010). Available from, as of March 30, 2011: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=33976


Norelgestromin and norgestrel are highly bound (>97%) to serum proteins. Norelgestromin is bound to albumin and not to SHBG, while norgestrel is bound primarily to SHBG.

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (December 2010). Available from, as of March 30, 2011: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=33976


The metabolites of norelgestromin and ethinyl estradiol are eliminated by renal and fecal pathways. Following administration of 14C-norgestimate, 47% (45-49%) and 37% (16-49%) of the administered radioactivity was eliminated in the urine and feces, respectively. Unchanged norgestimate was not detected in the urine.

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (December 2010). Available from, as of March 30, 2011: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=33976


5.4 Metabolism/Metabolites

Norgestimate is rapidly deacetylated to the active 17-desacetylnorgestimate, which is deoximated to the active norgestrel. 17-desacetylnorgestimate is metabolized to a number of undefined hydroxylated metabolites, mainly by CYP3A4 and to a lesser extend by CYP2B6 and CYP2C9. Norgestrel is O-glucuronidated by UGT1A1 or oxidized to a number of undefined hydroxylated metabolites by CYP3A4.


Norgestimate is rapidly and completely metabolized by first pass (intestinal and/or hepatic) mechanisms to norelgestromin (NGMN) and norgestrel (NG), which are the major active metabolites of norgestimate.

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (December 2010). Available from, as of March 30, 2011: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=33976


Norgestimate is extensively metabolized by first-pass mechanisms in the gastrointestinal tract and/or liver. Norgestimate's primary active metabolite is norelgestromin. Subsequent hepatic metabolism of norelgestromin occurs and metabolites include norgestrel, which is also active, and various hydroxylated and conjugated metabolites.

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (December 2010). Available from, as of March 30, 2011: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=33976


In addition to 17-deacetyl norgestimate, a number of metabolites of norgestimate have been identified in human urine following administration of radiolabeled norgestimate. These include 18,19-Dinor-17-pregn-4-en-20-yn-3-one,17-hydroxy-13-ethyl,(17alpha)-(-); 18,19-Dinor-5beta-17-pregnan-20-yn,3alpha,17beta-dihydroxy-13-ethyl,(17alpha), various hydroxylated metabolites and conjugates of these metabolites.

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (December 2010). Available from, as of March 30, 2011: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=33976


There is limited information on the metabolism of levonorgestrel, norethindrone and structurally related contraceptive steroids. Both levonorgestrel and norethindrone undergo extensive reduction of the alpha, beta-unsaturated ketone in ring A. Levonorgestrel also undergoes hydroxylation at carbons 2 and 16. The metabolites of both compounds circulate predominantly as sulfates. In urine, levonorgestrel metabolites are found primarily in the glucuronide form, whereas norethindrone metabolites are present in approximately equal amounts as sulfates and glucuronides. Of the progestogens structurally related to norethindrone, norethindrone acetate, ethynodiol diacetate, norethindrone enanthate, and perhaps lynestrenol, undergo rapid hydrolysis and are converted to the parent compound and its metabolites. There is no convincing evidence that norethynodrel is converted to norethindrone. Of the progestogens structurally related to levonorgestrel, it appears that neither desogestrel nor gestodene are transformed to the parent compound. However, there is evidence that norgestimate can be, at least partly, converted to levonorgestrel. ...

PMID:2143719 Stanczyk FZ, Roy S; Contraception 42 (1): 67-96 (1990)


5.5 Biological Half-Life

Norgestimate is rapidly deacetylated. The active metabolites of norgestimate, 17-desacetyl norgestimate, has a half life of 12-30h, while norgestrel has a half life of 36.410.2h.


5.6 Mechanism of Action

Progesterone analogs like norgestimate decrease the frequency of gonadotropin releasing hormone pulses from the hypothalamus, decreasing follicle stimulating hormone and luteinizing hormone. These actions prevent ovulation. Norgestimate suppresses the hypothalamo-pituitary-axis, reducing androgen synthesis. It also induces production of sex hormone binding globulin, which decreases free testosterone. These actions together result in less testosterone being available to stimulate sebaceous glands, resulting in effective treatment of some forms of acne.


Combination oral contraceptives act by suppression of gonadotropins. Although the primary mechanism of this action is inhibition of ovulation, other alterations include changes in the cervical mucus (which increase the difficulty of sperm entry into the uterus) and the endometrium (which reduce the likelihood of implantation).

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (December 2010). Available from, as of March 30, 2011: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=33976


Receptor binding studies, as well as studies in animals and humans, have shown that norgestimate and 17-deacetyl norgestimate, the major serum metabolite, combine high progestational activity with minimal intrinsic androgenicity. Norgestimate, in combination with ethinyl estradiol, does not counteract the estrogen-induced increases in sex hormone binding globulin (SHBG), resulting in lower serum testosterone.

US Natl Inst Health; DailyMed. Current Medication Information for MONONESSA (norgestimate and ethinyl estradiol) kit (December 2010). Available from, as of March 30, 2011: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=33976


Progestins enter target cells by passive diffusion and bind to cytosolic (soluble) receptors that are loosely bound in the nucleus. The steroid receptor complex initiates transcription, resulting in an increase in protein synthesis. /Progestins/

USP. Convention. USPDI - Drug Information for the Health Care Professional. 20th ed. Volume I. Micromedex, Inc. Englewood, CO., 2000. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 2568


Progestins are capable of affecting serum concentrations of other hormones, particularly estrogen. Estrogenic effects are modified by the progestins, either by reducing the availability or stability of the hormone receptor complex or by turning off specific hormone-responsive genes by direct interaction with the progestin receptor in the nucleus. In addition, estrogen priming is necessary to increase progestin effects by upregulating the number of progestin receptors and/or increasing progesterone production, causing a negative feedback mechanism that inhibits estrogen receptors. /Progestins/

USP. Convention. USPDI - Drug Information for the Health Care Professional. 20th ed. Volume I. Micromedex, Inc. Englewood, CO., 2000. Content Reviewed and Approved by the U.S. Pharmacopeial Convention, Inc., p. 2568


API SUPPLIERS

read-more
read-more

01

Sanofi

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Sanofi Company Banner

02

TAPI Technology & API Services

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
TAPI Company Banner

03

Gedeon Richter

Hungary

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

The Battery Show Europe
Not Confirmed
arrow

Gedeon Richter

Hungary

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
The Battery Show Europe
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

Industriale Chimica

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

The Battery Show Europe
Not Confirmed
arrow

Industriale Chimica

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
The Battery Show Europe
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

05

Industriale Chimica

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

The Battery Show Europe
Not Confirmed
arrow

Industriale Chimica

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
The Battery Show Europe
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

06

Sterling Spa

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

The Battery Show Europe
Not Confirmed
arrow

Sterling Spa

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
The Battery Show Europe
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

07

Gador SA

Argentina

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

The Battery Show Europe
Not Confirmed
arrow

Gador SA

Argentina

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
The Battery Show Europe
Not Confirmed
USDMF arrow-down CEP/COS Inactive-api JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Lupin Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

The Battery Show Europe
Not Confirmed
arrow

Lupin Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
The Battery Show Europe
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Gedeon Richter

Hungary

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

The Battery Show Europe
Not Confirmed
arrow

Gedeon Richter

Hungary

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
The Battery Show Europe
Not Confirmed
USDMF Inactive-api CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Merck & Co

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

The Battery Show Europe
Not Confirmed
arrow

Merck & Co

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
The Battery Show Europe
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Sanofi Chimie

France
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Flag France
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 2364

Submission : 1974-11-26

Status : Inactive

Type : II

Sanofi Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 14241

Submission : 1999-06-25

Status : Active

Type : II

TAPI Company Banner

03

Gador Sa

Argentina

USDMF

arrow
The Battery Show Europe
Not Confirmed

03

Gador Sa

Argentina
arrow
The Battery Show Europe
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 16271

Submission : 2002-11-26

Status : Active

Type : II

blank

04

Gedeon Richter Plc

Hungary

USDMF

arrow
The Battery Show Europe
Not Confirmed

04

The Battery Show Europe
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2017-05-02

Pay. Date : 2017-04-18

DMF Number : 19429

Submission : 2006-05-15

Status : Active

Type : II

blank

05

Gedeon Richter Plc

Hungary

USDMF

arrow
The Battery Show Europe
Not Confirmed

05

The Battery Show Europe
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 5708

Submission : 1985-01-21

Status : Inactive

Type : II

blank

06

The Battery Show Europe
Not Confirmed

06

The Battery Show Europe
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2021-03-11

Pay. Date : 2020-09-28

DMF Number : 33444

Submission : 2019-02-05

Status : Active

Type : II

blank

07

The Battery Show Europe
Not Confirmed

07

The Battery Show Europe
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 21518

Submission : 2008-04-09

Status : Active

Type : II

blank

08

Lupin Ltd

India

USDMF

arrow
The Battery Show Europe
Not Confirmed

08

Lupin Ltd

India
arrow
The Battery Show Europe
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 22726

Submission : 2009-04-15

Status : Active

Type : II

blank

09

Nv Organon

U.S.A

USDMF

arrow
The Battery Show Europe
Not Confirmed

09

Nv Organon

U.S.A
arrow
The Battery Show Europe
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 19327

Submission : 2006-04-06

Status : Inactive

Type : II

blank

10

Sterling Spa

Italy

USDMF

arrow
The Battery Show Europe
Not Confirmed

10

Sterling Spa

Italy
arrow
The Battery Show Europe
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2013-04-23

Pay. Date : 2013-04-11

DMF Number : 15649

Submission : 2001-10-04

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more

01

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

Certificate Number : R0-CEP 2010-012 - Rev 00

Status : Expired

Issue Date : 2011-11-17

Type : Chemical

Substance Number : 1732

blank

02

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

Certificate Number : R1-CEP 2009-125 - Rev 01

Status : Valid

Issue Date : 2021-12-02

Type : Chemical

Substance Number : 1732

blank

03

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

Certificate Number : CEP 2017-189 - Rev 01

Status : Valid

Issue Date : 2023-09-28

Type : Chemical

Substance Number : 1732

blank

06

The Battery Show Europe
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

NDC Package Code : 63190-0610

Start Marketing Date : 2008-04-09

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

Sicor S.r.l.

Italy
The Battery Show Europe
Not Confirmed
arrow

Sicor S.r.l.

Italy
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

NDC Package Code : 53183-7515

Start Marketing Date : 2010-10-31

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

NDC Package Code : 64918-1003

Start Marketing Date : 2015-03-06

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

04

STERLING SPA

Italy
The Battery Show Europe
Not Confirmed
arrow

STERLING SPA

Italy
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

NDC Package Code : 64918-1400

Start Marketing Date : 2010-11-11

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

ASG Biochem

India
The Battery Show Europe
Not Confirmed
arrow

ASG Biochem

India
arrow
The Battery Show Europe
Not Confirmed

Norgestimate

About the Company : ASG Biochem Private Limited at Ganganagar near Kolkata, West Bengal, India, is a bulk API manufacturing company of the New Delhi based diversified APEEJAY STYA GROUP. The unit acqu...

ASG Biochem Private Limited at Ganganagar near Kolkata, West Bengal, India, is a bulk API manufacturing company of the New Delhi based diversified APEEJAY STYA GROUP. The unit acquired from AKZO NOBEL N.V., the Netherlands in 2004 is engaged in the synthesis of specialized APIs, in particular, hormones and intermediates.The unit has global exports including intermediates / penultimates to the European Union apart from supply to internal Group companies. In addition, the plant also holds ISO 9001-2008 and ISO 14001:2004 certification from DNV, the Netherlands.The unit has Japan accreditation for manufacturing APIs.
blank

02

CHEMO

Spain
The Battery Show Europe
Not Confirmed
arrow

CHEMO

Spain
arrow
The Battery Show Europe
Not Confirmed

Norgestimate

About the Company : More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, ...

More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, and starts business activities trading with pharmaceutical raw materials. In the 80's, the company expanded its operations into the Industrial Business, developing and manufacturing active pharmaceutical ingredients (APIs) in Italy (Industriale Chimica) and in Spain (Quimica Sintetica). In the 90's, CHEMO starts developing and manufacturing high quality and technology finished dosage forms (FDFs).
blank

03

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

Norgestimate

About the Company : Industriale Chimica is a subsidiary of the CHEMO Group and is devoted to the manufacture of APIs for the pharmaceutical industry.

blank

04

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

Norgestimate

About the Company : Sicor’s plants provide a global platform for the manufacture and marketing of APIs for injectable, inhalation, topical and nasal products. These specialized plants possess a high...

Sicor’s plants provide a global platform for the manufacture and marketing of APIs for injectable, inhalation, topical and nasal products. These specialized plants possess a high level of expertise in the production of steroids, hormones and cytotoxic products. Sicor produces about 60 active ingredients and offers one of the widest ranges of anti-cancer drugs on the market today.
blank

05

Sterling Spa

Italy
The Battery Show Europe
Not Confirmed
arrow

Sterling Spa

Italy
arrow
The Battery Show Europe
Not Confirmed

Norgestimate

About the Company : The Quality Assurance department is the Guardian of Quality within the Company. We have a team dedicated to identifying and implementing new ICH guidelines. Our team is prepared ...

The Quality Assurance department is the Guardian of Quality within the Company. We have a team dedicated to identifying and implementing new ICH guidelines. Our team is prepared to obtain quality objectives which have been universally recognized by Inspection Authorities and the most important Pharmaceutical Companies from around the globe. This system is periodically verified through internal, national and international inspectors who have been able to recognize the high level obtained by the system and the actual achievement of quality objectives multiple times. Sterling has been inspected three times by FDA .
blank

06

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

Norgestimate

About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and...

Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
blank

07

Unipex

France
The Battery Show Europe
Not Confirmed
arrow

Unipex

France
arrow
The Battery Show Europe
Not Confirmed

Norgestimate

About the Company : Our work in the distribution sector starts and ends with the quality of human relations; first and foremost, it is trust that we want to build with you. The connections we build ar...

Our work in the distribution sector starts and ends with the quality of human relations; first and foremost, it is trust that we want to build with you. The connections we build are made to last. They are built on professionalism, respect and transparency. This is how we work, and how we have been working for a long time now, with our client partners and constituents. Unipex has been operational for 50 years, and has always remained true to its core business: the distribution of specialities. This is also why we are independent and we intend to stay that way. Our structure is simple, our commitment is absolute: we work directly with you.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1664389800,"product":"NORGESTIMATE USP (NORGESTIMATE MICRONIZED USP) BATCH NO.NGC-001\/21 L21376A1","address":"B\/2 MAHALAXMI CHAMBERS 22 BHULABHAI DESAI ROAD Contact No:","city":"MUMBAI","supplier":"STERLING SPA","supplierCountry":"ITALY","foreign_port":"NA","customer":"GLENMARK PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"2.76","actualQuantity":"2.763","unit":"KGS","unitRateFc":"12000","totalValueFC":"33263.1","currency":"USD","unitRateINR":"964800","date":"29-Sep-2022","totalValueINR":"2665742.4","totalValueInUsd":"33263.1","indian_port":"BOMBAY AIR","hs_no":"29372300","bill_no":"2656817","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Micronized","supplierPort":"NA","supplierAddress":"","customerAddress":"B\/2 MAHALAXMI CHAMBERS 22 BHULABHAI DESAI ROAD Contact No:"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1664389800,"product":"NORGESTIMATE USP (NORGESTIMATE MICRONIZED USP) BATCH NO.NGC-001\/21 L21376A1","address":"B\/2 MAHALAXMI CHAMBERS 22 BHULABHAI DESAI ROAD Contact No:","city":"MUMBAI","supplier":"STERLING SPA","supplierCountry":"ITALY","foreign_port":"NA","customer":"GLENMARK PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"7.24","actualQuantity":"7.237","unit":"KGS","unitRateFc":"12000","totalValueFC":"87124.6","currency":"USD","unitRateINR":"964800","date":"29-Sep-2022","totalValueINR":"6982257.6","totalValueInUsd":"87124.6","indian_port":"BOMBAY AIR","hs_no":"29372300","bill_no":"2656817","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Micronized","supplierPort":"NA","supplierAddress":"","customerAddress":"B\/2 MAHALAXMI CHAMBERS 22 BHULABHAI DESAI ROAD Contact No:"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1668969000,"product":"NORGESTIMATE USP (INTERNAL CODE:200457) (BATCH NO.NGC-003\/18L22168A1) NORGESTIMATE MICRONIZED USP","address":"B\/2 MAHALAXMI CHAMBERS 22 BHULABHAI DESAI ROAD Contact No:","city":"MUMBAI","supplier":"STERLING SPA","supplierCountry":"ITALY","foreign_port":"NA","customer":"GLENMARK PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"0.67","actualQuantity":"0.67","unit":"KGS","unitRateFc":"12000","totalValueFC":"8137.3","currency":"USD","unitRateINR":"991200","date":"21-Nov-2022","totalValueINR":"664104","totalValueInUsd":"8137.3","indian_port":"BOMBAY AIR","hs_no":"29372300","bill_no":"3401876","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Micronized","supplierPort":"NA","supplierAddress":"","customerAddress":"B\/2 MAHALAXMI CHAMBERS 22 BHULABHAI DESAI ROAD Contact No:"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1701801000,"product":"NORGESTIMATE USP (NORGESTIMATE MICRONIZED USP) BATCH NO.NGC-002\/21 L21495A1","address":"B\/2 MAHALAXMI CHAMBERS","city":"MUMBAI. MAHARASHTRA","supplier":"STERLING SPA","supplierCountry":"ITALY","foreign_port":"ROME","customer":"GLENMARK PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"4.83","actualQuantity":"4.831","unit":"KGS","unitRateFc":"12000","totalValueFC":"58568.7","currency":"USD","unitRateINR":"1009200","date":"06-Dec-2023","totalValueINR":"4875445.2","totalValueInUsd":"58568.7","indian_port":"Bombay Air","hs_no":"29372300","bill_no":"9093396","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Micronized","supplierPort":"ROME","supplierAddress":"VIA DELLA CARBONERIA 30,SOLOMEO06073 CORCIANO (PG),SDNF ITALY","customerAddress":"B\/2 MAHALAXMI CHAMBERS"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703529000,"product":"NORGESTIMATE MICRONIZED","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"STERLING SPA","supplierCountry":"ITALY","foreign_port":"N\/A","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"40.00","actualQuantity":"40","unit":"KGS","unitRateFc":"11577.2","totalValueFC":"466185.9","currency":"USD","unitRateINR":"970169.5","date":"26-Dec-2023","totalValueINR":"38806781","totalValueInUsd":"466185.9","indian_port":"Indore-EPZ\/SEZ","hs_no":"29372300","bill_no":"1008439","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Micronized","supplierPort":"N\/A","supplierAddress":"VIA DELLA CARBONERIA 30 06073 SOLOMEO DI CORCIANO - PG , ITALY","customerAddress":"159, C.S.T. ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703788200,"product":"NORGESTIMATE USP (NORGESTIMATE MICRONIZED USP) BATCH NO.NGC-001\/23 L23551A1","address":"B\/2 MAHALAXMI CHAMBERS","city":"MUMBAI. MAHARASHTRA","supplier":"STERLING SPA","supplierCountry":"ITALY","foreign_port":"ROME","customer":"GLENMARK PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"4.63","actualQuantity":"4.63","unit":"KGS","unitRateFc":"12000","totalValueFC":"55931.7","currency":"USD","unitRateINR":"1005600","date":"29-Dec-2023","totalValueINR":"4655928","totalValueInUsd":"55931.7","indian_port":"Bombay Air","hs_no":"29372300","bill_no":"9463628","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Micronized","supplierPort":"ROME","supplierAddress":"VIA DELLA CARBONERIA 30,SOLOMEO06073 CORCIANO (PG),SDNF ITALY","customerAddress":"B\/2 MAHALAXMI CHAMBERS"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703788200,"product":"NORGESTIMATE USP (NORGESTIMATE MICRONIZED USP) BATCH NO.NGC-001\/23 L23551A1","address":"B\/2 MAHALAXMI CHAMBERS","city":"MUMBAI. MAHARASHTRA","supplier":"STERLING SPA","supplierCountry":"ITALY","foreign_port":"ROME","customer":"GLENMARK PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"5.37","actualQuantity":"5.37","unit":"KGS","unitRateFc":"12000","totalValueFC":"64871.1","currency":"USD","unitRateINR":"1005600","date":"29-Dec-2023","totalValueINR":"5400072","totalValueInUsd":"64871.1","indian_port":"Bombay Air","hs_no":"29372300","bill_no":"9463628","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Micronized","supplierPort":"ROME","supplierAddress":"VIA DELLA CARBONERIA 30,SOLOMEO06073 CORCIANO (PG),SDNF ITALY","customerAddress":"B\/2 MAHALAXMI CHAMBERS"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720463400,"product":"NORGESTIMATE MICRONIZED","address":"PLOT NO.2, MAITRIVIHAR,","city":"HYDERABAD\/ANDHRA PRADESH","supplier":"STERLING SPA","supplierCountry":"ITALY","foreign_port":"ROME (ROMA), RM","customer":"AUROBINDO PHARMA LTD","customerCountry":"INDIA","quantity":"13.00","actualQuantity":"13","unit":"KGS","unitRateFc":"12040.6","totalValueFC":"157855.5","currency":"USD","unitRateINR":"1015024.1","date":"09-Jul-2024","totalValueINR":"13195313","totalValueInUsd":"157855.5","indian_port":"SEZ\/Mahaboobnagar","hs_no":"29372300","bill_no":"1002212","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Micronized","supplierPort":"ROME (ROMA), RM","supplierAddress":"VIA DELLA CARBONERIA 30 06073 SOLOM EO DI CORCIANO-PG ITALY, , Italy Italy","customerAddress":"PLOT NO.2, MAITRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731436200,"product":"NORGESTIMATE MICRONIZED","address":"PLOT NO.2, MAITRIVIHAR,","city":"HYDERABAD\/ANDHRA PRADESH","supplier":"STERLING SPA","supplierCountry":"ITALY","foreign_port":"FLORINAS","customer":"AUROBINDO PHARMA LTD","customerCountry":"INDIA","quantity":"15.00","actualQuantity":"15","unit":"KGS","unitRateFc":"12500","totalValueFC":"189303.8","currency":"USD","unitRateINR":"1065000","date":"13-Nov-2024","totalValueINR":"15975000","totalValueInUsd":"189303.8","indian_port":"SEZ\/Mahaboobnagar","hs_no":"29372300","bill_no":"6649260","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Micronized","supplierPort":"FLORINAS","supplierAddress":"VIA DELLA CARBONERIA 30 SOLOMEO 06073 SDNF Italy","customerAddress":"PLOT NO.2, MAITRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1740767400,"product":"NORGESTIMATE USP (NORGESTIMATE MICRONIZED USP) (BATCH NO.NGC-001\/23 L23551A1)NORGESTIMATE USP (NORGESTIMATE MICRONIZED USP) (BATCH NO.NGC","address":"B\/2 MAHALAXMI CHAMBERS","city":"MUMBAI. MAHARASHTRA","supplier":"STERLING SPA","supplierCountry":"ITALY","foreign_port":"ROME","customer":"GLENMARK PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"0.37","actualQuantity":"0.37","unit":"KGS","unitRateFc":"10000","totalValueFC":"3748.4","currency":"USD","unitRateINR":"877500","date":"01-Mar-2025","totalValueINR":"324675","totalValueInUsd":"3748.4","indian_port":"Bombay Air","hs_no":"29372300","bill_no":"8642840","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Micronized","supplierPort":"ROME","supplierAddress":"VIA DELLA CARBONERIA 30,SOLOMEO0607 3 CORCIANO (PG), SDNF ITALY","customerAddress":"B\/2 MAHALAXMI CHAMBERS"}]
29-Sep-2022
01-Mar-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

FDF Dossiers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Norgestimate

Brand Name : Norgestimate; Ethinyl Estradiol

Dosage Form : Tablet

Dosage Strength : 0.180MG; 0.035 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Norgestimate

Brand Name : Norgestimate; Ethinyl Estradiol

Dosage Form : Tablet

Dosage Strength : 0.215MG; 0.035 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothStrides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Norgestimate

Brand Name : Norgestimate; Ethinyl Estradiol

Dosage Form : Tablet

Dosage Strength : 0.25MG; 0.035 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

04

Actavis Inc

Ireland
The Battery Show Europe
Not Confirmed
arrow

Actavis Inc

Ireland
arrow
The Battery Show Europe
Not Confirmed

ETHINYL ESTRADIOL; NORGESTIMATE

Brand Name : NORGESTIMATE AND ETHINYL ESTRADIOL

Dosage Form : TABLET;ORAL-28

Dosage Strength : 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG

Packaging :

Approval Date : 2006-08-17

Application Number : 76626

Regulatory Info : DISCN

Registration Country : USA

blank

05

Apotex Inc

Canada
The Battery Show Europe
Not Confirmed
arrow

Apotex Inc

Canada
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

Brand Name : TRI-CIRA LO 21

Dosage Form : TABLET

Dosage Strength : 0.18MG

Packaging : 21

Approval Date :

Application Number : 2401967

Regulatory Info : Prescription

Registration Country : Canada

blank

06

Apotex Inc

Canada
The Battery Show Europe
Not Confirmed
arrow

Apotex Inc

Canada
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

Brand Name : TRI-CIRA 21

Dosage Form : TABLET

Dosage Strength : 0.215MG

Packaging :

Approval Date :

Application Number : 2508087

Regulatory Info : Prescription

Registration Country : Canada

blank

07

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

ETHINYL ESTRADIOL; NORGESTIMATE

Brand Name : TRI-MILI

Dosage Form : TABLET;ORAL-28

Dosage Strength : 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG

Packaging :

Approval Date : 2016-07-06

Application Number : 205441

Regulatory Info : RX

Registration Country : USA

blank

08

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

ESTRADIOL; NORGESTIMATE

Brand Name : ESTRADIOL AND NORGESTIMATE

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG,1MG;N/A,0.09MG

Packaging :

Approval Date : 2005-04-29

Application Number : 76812

Regulatory Info : DISCN

Registration Country : USA

blank

09

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

ETHINYL ESTRADIOL; NORGESTIMATE

Brand Name : NORGESTIMATE AND ETHINYL ESTRADIOL

Dosage Form : TABLET;ORAL-28

Dosage Strength : 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG

Packaging :

Approval Date : 2011-06-17

Application Number : 200494

Regulatory Info : RX

Registration Country : USA

blank

10

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

Norgestimate and estrogen

Brand Name : Reminyl Cr 8Mg

Dosage Form : CAP

Dosage Strength : 8mg

Packaging : 28X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

WATSON LABS

Ireland
The Battery Show Europe
Not Confirmed
arrow

WATSON LABS

Ireland
arrow
The Battery Show Europe
Not Confirmed

ETHINYL ESTRADIOL; NORGESTIMATE

Brand Name : NORGESTIMATE AND ETHINYL ESTRADIOL

Dosage Form : TABLET;ORAL-28

Dosage Strength : 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG

Approval Date : 2011-03-09

Application Number : 90479

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

02

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

ETHINYL ESTRADIOL; NORGESTIMATE

Brand Name : NORGESTIMATE AND ETHINYL ESTRADIOL

Dosage Form : TABLET;ORAL-28

Dosage Strength : 0.035MG;0.25MG

Approval Date : 2015-10-27

Application Number : 203865

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

03

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

ETHINYL ESTRADIOL; NORGESTIMATE

Brand Name : NORGESTIMATE AND ETHINYL ESTRADIOL

Dosage Form : TABLET;ORAL-28

Dosage Strength : 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG

Approval Date : 2015-11-12

Application Number : 203870

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

04

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

ETHINYL ESTRADIOL; NORGESTIMATE

Brand Name : TRI-LO-MILI

Dosage Form : TABLET;ORAL-28

Dosage Strength : 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG

Approval Date : 2016-11-04

Application Number : 205762

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

05

BARR

U.S.A
The Battery Show Europe
Not Confirmed
arrow

BARR

U.S.A
arrow
The Battery Show Europe
Not Confirmed

ETHINYL ESTRADIOL; NORGESTIMATE

Brand Name : SPRINTEC

Dosage Form : TABLET;ORAL-28

Dosage Strength : 0.035MG;0.25MG

Approval Date : 2002-09-25

Application Number : 75804

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

06

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

ETHINYL ESTRADIOL; NORGESTIMATE

Brand Name : TRI LO SPRINTEC

Dosage Form : TABLET;ORAL-28

Dosage Strength : 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG

Approval Date : 2009-06-29

Application Number : 76784

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

07

BARR

U.S.A
The Battery Show Europe
Not Confirmed
arrow

BARR

U.S.A
arrow
The Battery Show Europe
Not Confirmed

ESTRADIOL; NORGESTIMATE

Brand Name : ESTRADIOL AND NORGESTIMATE

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG,1MG;N/A,0.09MG

Approval Date : 2005-04-29

Application Number : 76812

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

08

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

ETHINYL ESTRADIOL; NORGESTIMATE

Brand Name : ORTHO CYCLEN-21

Dosage Form : TABLET;ORAL-21

Dosage Strength : 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1989-12-29

Application Number : 19653

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

09

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

ETHINYL ESTRADIOL; NORGESTIMATE

Brand Name : ORTHO TRI-CYCLEN 28

Dosage Form : TABLET; ORAL-28

Dosage Strength : 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG

Approval Date :

Application Number : 21690

RX/OTC/DISCN :

RLD :

TE Code :

blank

10

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

ETHINYL ESTRADIOL; NORGESTIMATE

Brand Name : NORGESTIMATE AND ETHINYL ESTRADIOL

Dosage Form : TABLET;ORAL-28

Dosage Strength : 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG

Approval Date : 2015-04-07

Application Number : 200383

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

read-more
read-more

01

APOTEX INC

Canada
The Battery Show Europe
Not Confirmed
arrow

APOTEX INC

Canada
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

Brand Name : TRI-CIRA LO 21

Dosage Form : TABLET

Dosage Strength : 0.18MG

Packaging : 21

Approval Date :

Application Number : 2401967

Regulatory Info : Prescription

Registration Country : Canada

blank

02

APOTEX INC

Canada
The Battery Show Europe
Not Confirmed
arrow

APOTEX INC

Canada
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

Brand Name : TRI-CIRA LO 28

Dosage Form : TABLET

Dosage Strength : 0.18MG

Packaging : 28

Approval Date :

Application Number : 2401975

Regulatory Info : Prescription

Registration Country : Canada

blank

03

APOTEX INC

Canada
The Battery Show Europe
Not Confirmed
arrow

APOTEX INC

Canada
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

Brand Name : TRI-CIRA LO 28

Dosage Form : TABLET

Dosage Strength : 0.215MG

Packaging : 28

Approval Date :

Application Number : 2401975

Regulatory Info : Prescription

Registration Country : Canada

blank

04

APOTEX INC

Canada
The Battery Show Europe
Not Confirmed
arrow

APOTEX INC

Canada
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

Brand Name : TRI-CIRA LO 28

Dosage Form : TABLET

Dosage Strength : 0.25MG

Packaging : 28

Approval Date :

Application Number : 2401975

Regulatory Info : Prescription

Registration Country : Canada

blank

05

APOTEX INC

Canada
The Battery Show Europe
Not Confirmed
arrow

APOTEX INC

Canada
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

Brand Name : TRI-CIRA 21

Dosage Form : TABLET

Dosage Strength : 0.25MG

Packaging :

Approval Date :

Application Number : 2508087

Regulatory Info : Prescription

Registration Country : Canada

blank

06

APOTEX INC

Canada
The Battery Show Europe
Not Confirmed
arrow

APOTEX INC

Canada
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

Brand Name : TRI-CIRA 28

Dosage Form : TABLET

Dosage Strength : 0.18MG

Packaging :

Approval Date :

Application Number : 2508095

Regulatory Info : Prescription

Registration Country : Canada

blank

07

APOTEX INC

Canada
The Battery Show Europe
Not Confirmed
arrow

APOTEX INC

Canada
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

Brand Name : TRI-CIRA 28

Dosage Form : TABLET

Dosage Strength : 0.215MG

Packaging :

Approval Date :

Application Number : 2508095

Regulatory Info : Prescription

Registration Country : Canada

blank

08

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

Brand Name : TRI-JORDYNA 21

Dosage Form : TABLET

Dosage Strength : 0.215MG

Packaging : 63 TABS (3 X 21)

Approval Date :

Application Number : 2486296

Regulatory Info : Prescription

Registration Country : Canada

blank

09

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

Brand Name : TRI-JORDYNA 21

Dosage Form : TABLET

Dosage Strength : 0.25MG

Packaging : 63 TABS (3 X 21)

Approval Date :

Application Number : 2486296

Regulatory Info : Prescription

Registration Country : Canada

blank

10

The Battery Show Europe
Not Confirmed
arrow
arrow
The Battery Show Europe
Not Confirmed

NORGESTIMATE

Brand Name : TRI-JORDYNA 28

Dosage Form : TABLET

Dosage Strength : 0.18MG

Packaging : 84 TABS (3 X 28)

Approval Date :

Application Number : 2486318

Regulatory Info : Prescription

Registration Country : Canada

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL-28 - 0.035MG;0.25MG **Fe...DOSAGE - TABLET;ORAL-28 - 0.035MG;0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 19653

read-more

DOSAGE - TABLET;ORAL-28 - 0.035MG,0.035MG,0.0...DOSAGE - TABLET;ORAL-28 - 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 19697

read-more

DOSAGE - TABLET;ORAL-28 - 0.025MG,0.025MG,0.0...DOSAGE - TABLET;ORAL-28 - 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 21241

read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 35189-28-7 / Norgestimate API manufacturers, exporters & distributors?

Norgestimate manufacturers, exporters & distributors 1

68

PharmaCompass offers a list of Norgestimate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Norgestimate manufacturer or Norgestimate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Norgestimate manufacturer or Norgestimate supplier.

PharmaCompass also assists you with knowing the Norgestimate API Price utilized in the formulation of products. Norgestimate API Price is not always fixed or binding as the Norgestimate Price is obtained through a variety of data sources. The Norgestimate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Norgestimate

Synonyms

Dexnorgestrel acetime, 35189-28-7, Anti-norgestimate, Norgestimate, e-, Norgestimato, Norgestimatum

Cas Number

35189-28-7

Unique Ingredient Identifier (UNII)

NKX8DN6TY9

About Norgestimate

Norgestimate was first described in the literature in 1977. It was developed by Ortho Pharmaceutical Corporation as part of an effort to develop new hormonal contraceptives with reduced adverse effects. It is commonly formulated with [ethinylestradiol] as a combined oral contraceptive that can also be used to treat moderate acne vulgaris. Norgestimate was granted FDA approval on 29 December 1989.

PREFEST-1 Manufacturers

A PREFEST-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PREFEST-1, including repackagers and relabelers. The FDA regulates PREFEST-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PREFEST-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of PREFEST-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

PREFEST-1 Suppliers

A PREFEST-1 supplier is an individual or a company that provides PREFEST-1 active pharmaceutical ingredient (API) or PREFEST-1 finished formulations upon request. The PREFEST-1 suppliers may include PREFEST-1 API manufacturers, exporters, distributors and traders.

click here to find a list of PREFEST-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

PREFEST-1 USDMF

A PREFEST-1 DMF (Drug Master File) is a document detailing the whole manufacturing process of PREFEST-1 active pharmaceutical ingredient (API) in detail. Different forms of PREFEST-1 DMFs exist exist since differing nations have different regulations, such as PREFEST-1 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A PREFEST-1 DMF submitted to regulatory agencies in the US is known as a USDMF. PREFEST-1 USDMF includes data on PREFEST-1's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The PREFEST-1 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of PREFEST-1 suppliers with USDMF on PharmaCompass.

PREFEST-1 CEP

A PREFEST-1 CEP of the European Pharmacopoeia monograph is often referred to as a PREFEST-1 Certificate of Suitability (COS). The purpose of a PREFEST-1 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of PREFEST-1 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of PREFEST-1 to their clients by showing that a PREFEST-1 CEP has been issued for it. The manufacturer submits a PREFEST-1 CEP (COS) as part of the market authorization procedure, and it takes on the role of a PREFEST-1 CEP holder for the record. Additionally, the data presented in the PREFEST-1 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the PREFEST-1 DMF.

A PREFEST-1 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. PREFEST-1 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of PREFEST-1 suppliers with CEP (COS) on PharmaCompass.

PREFEST-1 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing PREFEST-1 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for PREFEST-1 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture PREFEST-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain PREFEST-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a PREFEST-1 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of PREFEST-1 suppliers with NDC on PharmaCompass.

PREFEST-1 GMP

PREFEST-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of PREFEST-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PREFEST-1 GMP manufacturer or PREFEST-1 GMP API supplier for your needs.

PREFEST-1 CoA

A PREFEST-1 CoA (Certificate of Analysis) is a formal document that attests to PREFEST-1's compliance with PREFEST-1 specifications and serves as a tool for batch-level quality control.

PREFEST-1 CoA mostly includes findings from lab analyses of a specific batch. For each PREFEST-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

PREFEST-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (PREFEST-1 EP), PREFEST-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PREFEST-1 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty